Evidence map›Paper›PMID 26487690›Full record

ArticleNeuro-oncology2016

Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium.

Tina Young Poussaint, Sridhar Vajapeyam, Kelsey I Ricci, Ashok Panigrahy, Mehmet Kocak, Larry E Kun, James M Boyett, Ian F Pollack, Maryam Fouladi

Open access · bronzeAbstract read
In one paragraph

Article in Neuro-oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 68 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Contemporary Management of Pediatric Brainstem Tumors.Advances and technical standards in neurosurgery · 2024
    Review
  6. Article
  7. Article
  8. European journal of nuclear medicine and molecular imaging · 2023
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Imaging diagnosis and treatment selection for brain tumors in the era of molecular therapeutics.Cancer imaging : the official publication of the International Cancer Imaging Society · 2022
    Review
  15. MR Imaging of Pediatric Brain Tumors.Diagnostics (Basel, Switzerland) · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Tina Young PoussaintDepartment of Radiology, Boston Children's Hospital, Boston, Massachusetts (T.Y.P., S.V., K.I.R.); Department of Radiology, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (A.P.); Department of Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, Tennessee (L.E.K.); Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee (M.K., J.M.B.); Department of Neurosurgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania (I.F.P.); Neuro-Oncology Program, Cincinnati Children's Hospital, Cincinnati, Ohio (M.F.).
Sridhar VajapeyamDepartment of Radiology, Boston Children's Hospital, Boston, Massachusetts (T.Y.P., S.V., K.I.R.); Department of Radiology, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (A.P.); Department of Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, Tennessee (L.E.K.); Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee (M.K., J.M.B.); Department of Neurosurgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania (I.F.P.); Neuro-Oncology Program, Cincinnati Children's Hospital, Cincinnati, Ohio (M.F.).
Kelsey I RicciDepartment of Radiology, Boston Children's Hospital, Boston, Massachusetts (T.Y.P., S.V., K.I.R.); Department of Radiology, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (A.P.); Department of Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, Tennessee (L.E.K.); Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee (M.K., J.M.B.); Department of Neurosurgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania (I.F.P.); Neuro-Oncology Program, Cincinnati Children's Hospital, Cincinnati, Ohio (M.F.).
Ashok PanigrahyDepartment of Radiology, Boston Children's Hospital, Boston, Massachusetts (T.Y.P., S.V., K.I.R.); Department of Radiology, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (A.P.); Department of Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, Tennessee (L.E.K.); Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee (M.K., J.M.B.); Department of Neurosurgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania (I.F.P.); Neuro-Oncology Program, Cincinnati Children's Hospital, Cincinnati, Ohio (M.F.).
Mehmet KocakDepartment of Radiology, Boston Children's Hospital, Boston, Massachusetts (T.Y.P., S.V., K.I.R.); Department of Radiology, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (A.P.); Department of Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, Tennessee (L.E.K.); Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee (M.K., J.M.B.); Department of Neurosurgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania (I.F.P.); Neuro-Oncology Program, Cincinnati Children's Hospital, Cincinnati, Ohio (M.F.).
Larry E KunDepartment of Radiology, Boston Children's Hospital, Boston, Massachusetts (T.Y.P., S.V., K.I.R.); Department of Radiology, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (A.P.); Department of Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, Tennessee (L.E.K.); Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee (M.K., J.M.B.); Department of Neurosurgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania (I.F.P.); Neuro-Oncology Program, Cincinnati Children's Hospital, Cincinnati, Ohio (M.F.).
James M BoyettDepartment of Radiology, Boston Children's Hospital, Boston, Massachusetts (T.Y.P., S.V., K.I.R.); Department of Radiology, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (A.P.); Department of Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, Tennessee (L.E.K.); Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee (M.K., J.M.B.); Department of Neurosurgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania (I.F.P.); Neuro-Oncology Program, Cincinnati Children's Hospital, Cincinnati, Ohio (M.F.).
Ian F PollackDepartment of Radiology, Boston Children's Hospital, Boston, Massachusetts (T.Y.P., S.V., K.I.R.); Department of Radiology, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (A.P.); Department of Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, Tennessee (L.E.K.); Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee (M.K., J.M.B.); Department of Neurosurgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania (I.F.P.); Neuro-Oncology Program, Cincinnati Children's Hospital, Cincinnati, Ohio (M.F.).
Maryam FouladiDepartment of Radiology, Boston Children's Hospital, Boston, Massachusetts (T.Y.P., S.V., K.I.R.); Department of Radiology, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (A.P.); Department of Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, Tennessee (L.E.K.); Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee (M.K., J.M.B.); Department of Neurosurgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania (I.F.P.); Neuro-Oncology Program, Cincinnati Children's Hospital, Cincinnati, Ohio (M.F.).
University of Pittsburgh Medical Center · USChildren's Hospital of Pittsburgh · USSt. Jude Children's Research Hospital · USBoston Children's Hospital · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Pediatric Brain Tumor Consortium (PBTC)UM1CA081457 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Ira J Dunkel, Arzu Onar-Thomas · 2014 to 2026
$41.4M
The Pediatric Brain Tumor Consortium (PBTC)U01CA081457 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI BOYETT, JAMES MILFORD · 1999 to 2013
$29.2M
NCI NIH HHS P30 CA021765NCI NIH HHS U01 CA081457NCI NIH HHS UM1 CA081457
6 · The paper itself

Abstract

backgroundDiffuse intrinsic pontine glioma (DIPG) is associated with poor survival regardless of therapy. We used volumetric apparent diffusion coefficient (ADC) histogram metrics to determine associations with progression-free survival (PFS) and overall survival (OS) at baseline and after radiation therapy (RT).

methodsBaseline and post-RT quantitative ADC histograms were generated from fluid-attenuated inversion recovery (FLAIR) images and enhancement regions of interest. Metrics assessed included number of peaks (ie, unimodal or bimodal), mean and median ADC, standard deviation, mode, skewness, and kurtosis.

resultsBased on FLAIR images, the majority of tumors had unimodal peaks with significantly shorter average survival. Pre-RT FLAIR mean, mode, and median values were significantly associated with decreased risk of progression; higher pre-RT ADC values had longer PFS on average. Pre-RT FLAIR skewness and standard deviation were significantly associated with increased risk of progression; higher pre-RT FLAIR skewness and standard deviation had shorter PFS. Nonenhancing tumors at baseline showed higher ADC FLAIR mean values, lower kurtosis, and higher PFS. For enhancing tumors at baseline, bimodal enhancement histograms had much worse PFS and OS than unimodal cases and significantly lower mean peak values. Enhancement in tumors only after RT led to significantly shorter PFS and OS than in patients with baseline or no baseline enhancement.

conclusionsADC histogram metrics in DIPG demonstrate significant correlations between diffusion metrics and survival, with lower diffusion values (increased cellularity), increased skewness, and enhancement associated with shorter survival, requiring future investigations in large DIPG clinical trials.

Indexed as

Brain Stem NeoplasmsChildDiffusion Magnetic Resonance ImagingDisease-Free SurvivalDisease ProgressionFemaleGliomaHumansImage Interpretation, Computer-AssistedKaplan-Meier EstimateMalePrognosisADC histogrambrainstem gliomabrain tumorMR diffusionpediatric

Identifiers

PMID26487690
PMCPMC4827042
OpenAlexW2178695764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.